Prevalence and Characteristics of INOCA in Patients With Either Angiographically Normal Vessels or Non-Obstructive

Adrián Jerónimo1, José G Paredes-Vázquez1, Marco Lombardi1

  • 1Department of Cardiology, Hospital Clinico San Carlos IDISSC, CIBER-CV and Universidad Complutense de Madrid, Madrid, Spain.

Insights

Myocardial ischemia of non-obstructive origin (INOCA) affects patients with and without coronary atherosclerosis similarly. Functional coronary testing is crucial for diagnosing INOCA, regardless of atherosclerosis presence.

Area of Science:

  • Cardiology
  • Vascular Medicine
  • Diagnostic Imaging

Background:

  • Myocardial ischemia of non-obstructive origin (INOCA) is a common cause of chronic coronary syndromes (CCS).
  • Atherosclerosis risk factors may also contribute to INOCA, prompting investigation into their clinical relationship.
  • The AID-ANGIO trial provides a platform for this sub-analysis.

Purpose of the Study:

  • To compare the prevalence and clinical characteristics of INOCA in patients with and without coronary atherosclerosis.
  • To determine if coronary atherosclerosis influences the presentation or diagnosis of INOCA.
  • To identify factors associated with INOCA endotypes.

Main Methods:

  • Sub-analysis of the prospective, multicentre AID-ANGIO study.
  • Coronary angiography and pressure guidewires used to assess obstructive coronary artery disease (CAD).
  • Functional coronary testing (FCT) performed for patients without obstructive-CAD; INOCA patients classified as INOCA-Ath (non-obstructive atherosclerosis) or INOCA-NoAth (normal coronary arteries).

Main Results:

  • Prevalence of INOCA-Ath (78.7%) and INOCA-NoAth (70.2%) was similar.
  • Patient symptoms, ischemia test results, and endotype distribution were comparable between groups.
  • Vasomotor abnormalities were the most frequent finding in both INOCA-Ath (81.4%) and INOCA-NoAth (74.0%) groups.

Conclusions:

  • INOCA prevalence is similar in patients with and without non-obstructive coronary atherosclerosis.
  • Clinical features and endotype distribution of INOCA do not significantly differ based on the presence of atherosclerosis.
  • Functional coronary testing is essential for accurate INOCA diagnosis.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
620
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948